Our feasibility study delivers a comprehensive financial and technical assessment tailored to the markets, identifying suitable pharmaceutical products for local manufacturing. It includes an in-depth review of market demographics, demand potential, regulatory requirements, competitive landscape, and financial viability, along with risk evaluation and mitigation strategies. The study is supported by conceptual engineering documentation to ensure that technical solutions are aligned with market realities and investment objectives.
We provide an integrated conceptual design aligned with the client’s business plan, defining pharmaceutical processes, required equipment, and facility layouts to ensure efficient production flow. The scope also includes establishing the project schedule and preparing a preliminary cost estimate to support early decision-making.
The Basic Design phase develops the approved conceptual design into coordinated and detailed technical documentation that defines system capacities, layout decisions, and design criteria. This phase includes the preparation of technical specifications, utility sizing, User Requirement Specifications (URS) for process and major utility equipment, Piping and Instrumentation Diagrams (P&IDs), and airflow or pressurization diagrams. The work is carried out through close multidisciplinary coordination to ensure compliance with GMP requirements, operational safety, reliability, and cost efficiency, while providing a more accurate project cost estimate compared to the conceptual stage.
We are committed to provide you with our most efficient and innovative design that fulfill the intended use, taking into consideration all quality, cost, and safety aspects, we take care of all details so as to assure that the production of the targeted items will will be successful, our integrated design package enable the customer to start the implementation of the project directly.
We offer top-notch site supervision and project management services, the detailed design and workshop drawings are implemented on site. Project launch is started through proper organization with all suppliers, contractors and sub-contractors and in full controlling/ monitoring with project owners
During the Construction and Execution Phase, Pharmaactive provides technical oversight and coordination to ensure that the approved detailed design and shop drawings are correctly implemented on site. Our role includes coordinating with suppliers, contractors, and subcontractors, reviewing technical submittals and shop drawings, and supporting site execution to ensure compliance with GMP requirements, design intent, and project specifications.
During this phase, commissioning and qualification activities are initiated and systematically coordinated. Monitoring and control of both processes are harmonized to ensure alignment, optimize execution, and minimize redundant qualification efforts. This integrated approach supports efficient validation, compliance with GMP requirements, and achievement of project objectives in an effective and controlled manner.
Handover phase is the final stage of an engineering project, where the completed pharmaceutical facility is formally transferred to the client. During this phase, all documentation, as-built drawings, operating manuals, and qualification records are handed over. Training is provided to the client’s team to ensure safe and efficient operation of the facility. Once all contractual requirements are met, the client officially accepts the project for operational use
Pharmaactive officially launched its Projects Department in 2020 as part of its strategic expansion in pharmaceutical engineering and project delivery.
First General Formulation manufacturing facility design delivered in PharmaActive’s project history.
Completed the First Feasibility Study on Iraqi Market and First Oncology Conceptual design Project.
Achieved a key milestone with the successful development of its first high-potent oncology facility (OSD and sterile)
delivering a fully coordinated detailed design based on the approved concept
PharmaActive’s first project management engagement.
Completion of the detailed design for the largest biotechnology manufacturing facility in the MENA region
First Bio-Technology Conceptual Design in PharmaActive.
Starting from Jordan, our operations expanded in 2021 to include design and consultancy services for pharmaceutical factories in the Iraqi and Saudi markets. In 2023, our regional presence further extended to Palestine and Lebanon, followed by entry into the Yemeni market in 2025. We continue to build on this growth and actively look forward to expanding into additional regional and international markets.